(Reuters) - Xiaflex is an injectable enzyme for the treatment of
Dupuytren's contracture, a condition caused when the fibrous
tissue in the palm thickens, causing fingers to curl.
In a statement, the specialty pharmaceutical company said
it plans to resume late-stage trials for Xiaflex in the fourth
quarter.
Read more at Reuters.com Market News
Dupuytren's contracture, a condition caused when the fibrous
tissue in the palm thickens, causing fingers to curl.
In a statement, the specialty pharmaceutical company said
it plans to resume late-stage trials for Xiaflex in the fourth
quarter.
Read more at Reuters.com Market News
No comments:
Post a Comment